Peptide YY and ghrelin predict craving and risk for relapse in abstinent smokers

Psychoneuroendocrinology

Volumn 49, Issue 1, 2014, Pages 253-259

  al'Absi, Mustafa ^a   Lemieux, Andrine ^a   Nakajima, Motohiro ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Craving; Ghrelin; Nicotine dependence; Peptide YY; Relapse; Withdrawal

Indexed keywords

GHRELIN; PEPTIDE YY; CARBON MONOXIDE; COTININE;

ADULT; AGE; ANALYSIS OF VARIANCE; ARTICLE; BODY MASS; CARBON MONOXIDE BLOOD LEVEL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEASIBILITY STUDY; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; MOTIVATION; PREDICTION; RELAPSE; RISK ASSESSMENT; SALIVA ANALYSIS; SEX DIFFERENCE; SLEEP; SLEEP TIME; SMOKING CESSATION; TOBACCO DEPENDENCE; WITHDRAWAL SYNDROME; BLOOD; METABOLISM; PHYSIOLOGY; PSYCHOLOGY; RECURRENT DISEASE; RISK FACTOR; SALIVA; YOUNG ADULT;

ADULT; CARBON MONOXIDE; COTININE; CRAVING; FEMALE; GHRELIN; HUMANS; MALE; PEPTIDE YY; RECURRENCE; RISK FACTORS; SALIVA; SMOKING CESSATION; SUBSTANCE WITHDRAWAL SYNDROME; YOUNG ADULT;

EID: 84917735148     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2014.07.018     Document Type: Article

References (46)

1. Abizaid A., Liu Z.W., Andrews Z.B., Shanabrough M., Borok E., Elsworth J.D., Horvath T.L. Ghrelin modulates the activity and synaptic input organization of midbrain dopamine neurons while promoting appetite. J. Clin. Invest. 2006, 116(12):3229-3239. 10.1172/jci29867.
2. Abizaid A. Ghrelin and dopamine: new insights on the peripheral regulation of appetite. J. Neuroendocrinol. 2009, 21(9):787-793. 10.1111/j.1365-2826.2009.01896.x.
3. Aguiar-Nemer A.S., Toffolo M.C., da Silva C.J., Laranjeira R., Silva-Fonseca V.A. Leptin influence in craving and relapse of alcoholics and smokers. J. Clin. Med. Res. 2013, 5(3):164-167. 10.4021/jocmr1159w.
4. al'Absi M., Hatsukami D., Davis G.L. Attenuated adrenocorticotropic responses to psychological stress are associated with early smoking relapse. Psychopharmacology 2005, 181(1):107-117.
5. al'Absi M., Nakajima M., Grabowski J. Stress response dysregulation and stress-induced analgesia in nicotine dependent men and women. Biol. Psychol. 2013, 93(1):1-8. 10.1016/j.biopsycho.2012.12.007.
6. Batterham R.L., Cowley M.A., Small C.J., Herzog H., Cohen M.A., Dakin C.L., Bloom S.R. Gut hormone PYY(3-36) physiologically inhibits food intake. Nature 2002, 418(6898):650-654. 10.1038/nature02666.
7. Challis B.G., Coll A.P., Yeo G.S., Pinnock S.B., Dickson S.L., Thresher R.R., O'Rahilly S. Mice lacking pro-opiomelanocortin are sensitive to high-fat feeding but respond normally to the acute anorectic effects of peptide-YY(3-36). Proc. Nat. Acad. Sci. U.S.A. 2004, 101(13):4695-4700. 10.1073/pnas.0306931101.
8. Challis B.G., Pinnock S.B., Coll A.P., Carter R.N., Dickson S.L., O'Rahilly S. Acute effects of PYY3-36 on food intake and hypothalamic neuropeptide expression in the mouse. Biochem. Biophys. Res. Commun. 2003, 311(4):915-919.
9. Cox L.S., Tiffany S.T., Christen A.G. Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settings. Nicotine Tob. Res. 2001, 3(1):7-16. 10.1080/14622200020032051.
10. Date Y., Kojima M., Hosoda H., Sawaguchi A., Mondal M.S., Suganuma T., Nakazato M. Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology 2000, 141(11):4255-4261. 10.1210/endo.141.11.7757.
11. Dickson S.L., Egecioglu E., Landgren S., Skibicka K.P., Engel J.A., Jerlhag E. The role of the central ghrelin system in reward from food and chemical drugs. Mol. Cell. Endocrinol. 2011, 340(1):80-87. 10.1016/j.mce.2011.02.017.
12. Ferguson S.G., Shiffman S. The relevance and treatment of cue-induced cravings in tobacco dependence. J. Subst. Abuse Treat 2009, 36(3):235-243. 10.1016/j.jsat.2008.06.005.
13. Heatherton T.F., Kozlowski L.T., Frecker R.C., Fagerstrom K.O. The Fagerstrom test for nicotine dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br. J. Addict. 1991, 86:1119-1127.
14. Hillemacher T. Biological mechanisms in alcohol dependence-new perspectives. Alcohol Alcohol. 2011, 46(3):224-230. 10.1093/alcalc/agr026.
15. Hughes J., Hatsukami D.K. Errors in using tobacco withdrawal scale. Tob. Control 1998, 7(1):92-93.
16. Hughes J.R., Hatsukami D. Signs and symptoms of tobacco withdrawal. Arch. Gen. Psychiatry 1986, 43(3):289-294.
17. Jerlhag E., Egecioglu E., Dickson S.L., Andersson M., Svensson L., Engel J.A. Ghrelin stimulates locomotor activity and accumbal dopamine-overflow via central cholinergic systems in mice: implications for its involvement in brain reward. Addict. Biol. 2006, 11(1):45-54. 10.1111/j.1369-1600.2006.00002.x.
18. Jerlhag E., Egecioglu E., Dickson S.L., Douhan A., Svensson L., Engel J.A. Ghrelin administration into tegmental areas stimulates locomotor activity and increases extracellular concentration of dopamine in the nucleus accumbens. Addict. Biol. 2007, 12(1):6-16. 10.1111/j.1369-1600.2006.00041.x.
19. Jerlhag E., Engel J.A. Ghrelin receptor antagonism attenuates nicotine-induced locomotor stimulation, accumbal dopamine release and conditioned place preference in mice. Drug Alcohol Depend. 2011, 117(2-3):126-131. 10.1016/j.drugalcdep.2011.01.010.
20. Jerlhag E., Janson A.C., Waters S., Engel J.A. Concomitant release of ventral tegmental acetylcholine and accumbal dopamine by ghrelin in rats. PLoS One 2012, 7(11):e49557. 10.1371/journal.pone.0049557.
21. Kenny P.J. Common cellular and molecular mechanisms in obesity and drug addiction. Nat. Rev. Neurosci. 2011, 12(11):638-651. 10.1038/nrn3105.
22. Kokkinos A., Tentolouris N., Kyriakaki E., Argyrakopoulou G., Doupis J., Psallas M., Katsilambros N. Differentiation in the short- and long-term effects of smoking on plasma total ghrelin concentrations between male nonsmokers and habitual smokers. Metabolism 2007, 56(4):523-527. 10.1016/j.metabol.2006.11.012.
23. Koopmann A., von der Goltz C., Grosshans M., Dinter C., Vitale M., Wiedemann K., Kiefer F. The association of the appetitive peptide acetylated ghrelin with alcohol craving in early abstinent alcohol dependent individuals. Psychoneuroendocrinology 2012, 37(7):980-986. 10.1016/j.psyneuen.2011.11.005.
24. Landgren S., Berglund K., Jerlhag E., Fahlke C., Balldin J., Berggren U., Engel J.A. Reward-related genes and personality traits in alcohol-dependent individuals: a pilot case control study. Neuropsychobiology 2011, 64(1):38-46. 10.1159/000324992.
25. Lee H., Joe K.-H., Kim W., Park J., Lee D.-H., Sung K.-W., Kim D.-J. Increased leptin and decreased ghrelin level after smoking cessation. Neurosci. Lett. 2006, 409(1):47-51. http://dx.doi.org/10.1016/j.neulet.2006.09.013.
26. Leggio L., Ferrulli A., Cardone S., Nesci A., Miceli A., Malandrino N., Addolorato G. Ghrelin system in alcohol-dependent subjects: role of plasma ghrelin levels in alcohol drinking and craving. Addict. Biol. 2012, 17(2):452-464. 10.1111/j.1369-1600.2010.00308.x.
27. Leggio L., Zywiak W.H., Fricchione S.R., Edwards S.M., de la Monte S.M., Swift R.M., Kenna G.A. Intravenous ghrelin administration increases alcohol craving in alcohol-dependent heavy drinkers: a preliminary investigation. Biol. Psychiatry 2014, In press. 10.1016/j.biopsych.2014.03.019.
28. Lutter M., Sakata I., Osborne-Lawrence S., Rovinsky S.A., Anderson J.G., Jung S., Zigman J.M. The orexigenic hormone ghrelin defends against depressive symptoms of chronic stress. Nat. Neurosci. 2008, 11(7):752-753. 10.1038/nn.2139.
29. Malik S., McGlone F., Bedrossian D., Dagher A. Ghrelin modulates brain activity in areas that control appetitive behavior. Cell Metab. 2008, 7(5):400-409. 10.1016/j.cmet.2008.03.007.
30. Menzies J.R., Skibicka K.P., Dickson S.L., Leng G. Neural substrates underlying interactions between appetite stress and reward. Obes. Facts 2012, 5(2):208-220. 10.1159/000338237.
31. Mutschler J., Graf N., Spanaus K.S., Rossler W., Hergan K., Binkert C.A., Gutzeit A. Circulating ghrelin levels are not associated with craving and withdrawal symptoms in acute nicotine withdrawal. Psychiatr. Danub. 2012, 24(2):229-230.
32. Nakazato M., Murakami N., Date Y., Kojima M., Matsuo H., Kangawa K., Matsukura S. A role for ghrelin in the central regulation of feeding. Nature 2001, 409(6817):194-198. 10.1038/35051587.
33. Painsipp E., Herzog H., Holzer P. Evidence from knockout mice that neuropeptide-Y Y2 and Y4 receptor signalling prevents long-term depression-like behaviour caused by immune challenge. J Psychopharmacol 2010, 24(10):1551-1560. 10.1177/0269881109348171.
34. Painsipp E., Herzog H., Sperk G., Holzer P. Sex-dependent control of murine emotional-affective behaviour in health and colitis by peptide YY and neuropeptide Y. Br. J. Pharmacol. 2011, 163(6):1302-1314. 10.1111/j.1476-5381.2011.01326.x.
35. Palotai M., Bagosi Z., Jaszberenyi M., Csabafi K., Dochnal R., Manczinger M., Szabo G. Ghrelin amplifies the nicotine-induced dopamine release in the rat striatum. Neurochem. Int. 2013, 63(4):239-243. 10.1016/j.neuint.2013.06.014.
36. Palotai M., Bagosi Z., Jaszberenyi M., Csabafi K., Dochnal R., Manczinger M., Szabo G. Ghrelin and nicotine stimulate equally the dopamine release in the rat amygdala. Neurochem. Res. 2013, 38(10):1989-1995. 10.1007/s11064-013-1105-1.
37. Pilhatsch M., Scheuing H., Kroemer N., Kobiella A., Bidlingmaier M., Farger G., Zimmermann U.S. Nicotine administration in healthy non-smokers reduces appetite but does not alter plasma ghrelin. Hum. Psychopharmacol. 2014, 10.1002/hup.2405.
38. Sakata I., Nakamura K., Yamazaki M., Matsubara M., Hayashi Y., Kangawa K., Sakai T. Ghrelin-producing cells exist as two types of cells, closed- and opened-type cells, in the rat gastrointestinal tract. Peptides 2002, 23(3):531-536.
39. Schloegl H., Percik R., Horstmann A., Villringer A., Stumvoll M. Peptide hormones regulating appetite-focus on neuroimaging studies in humans. Diabetes Metab. Res. Rev. 2011, 27(2):104-112. 10.1002/dmrr.1154.
40. Suchankova P., Jerlhag E., Jayaram-Lindström N., Nilsson S., Toren K., Rosengren A., Franck J. Genetic variation of the ghrelin signalling system in individuals with amphetamine dependence. PLoS One 2013, 8(4):e61242. 10.1371/journal.pone.0061242.
41. Tiffany S.T., Drobes D.J. The development and initial validation of a questionnaire on smoking urges. Br. J. Addict. 1991, 86(11):1467-1476.
42. Valassi E., Scacchi M., Cavagnini F. Neuroendocrine control of food intake. Nutr. Metab. Cardiovasc. Dis. 2008, 18(2):158-168. 10.1016/j.numecd.2007.06.004.
43. Volkow N.D., Wang G.J., Fowler J.S., Tomasi D., Baler R. Food and drug reward: overlapping circuits in human obesity and addiction. Curr. Top. Behav. Neurosci. 2012, 11:1-24. 10.1007/7854_2011_169.
44. Wren A.M., Bloom S.R. Gut hormones and appetite control. Gastroenterology 2007, 132(6):2116-2130. 10.1053/j.gastro.2007.03.048.
45. Xu Y., Elmquist J.K., Fukuda M. Central nervous control of energy and glucose balance: focus on the central melanocortin system. Ann. N.Y. Acad. Sci. 2011, 1243:1-14. 10.1111/j.1749-6632.2011.06248.x.
46. Zac-Varghese S., De Silva A., Bloom S.R. Translational studies on PYY as a novel target in obesity. Curr. Opin. Pharmacol. 2011, 11(6):582-585. 10.1016/j.coph.2011.10.001.